-
Stevan Djuric
Senior Director, AbbVie, United Kingdom
-
John Wise
Executive Director, Pistoia Alliance, United Kingdom
-
Mark O'Neil Johnson
VP Analytical Chemistry, Sequoia Sciences, United Kingdom
-
Craig Wegner
Executive Director Translational Science, AstraZeneca, United Kingdom
-
Wendy Hamilton
Global Head Life Sciences, Thomson Reuters, United Kingdom
-
Attila Berces
Founder and Chairman, Omixon, United Kingdom
-
Scott Thomas
Director for Biology, Genetics, and Pharmacogenomics IT, United Kingdom
-
Gyorgy Abel
Director, Clinical Chemistry, Molecular Diagnostics, United Kingdom
-
Aaron Sato
Vice President of Research, Sutro Biopharma, United Kingdom
-
Nikolaos Tezapsidis
President & CEO, Neutrotez, United Kingdom
-
Martin Moorhead
Vice President of Computational Biology and Informatics, United Kingdom
-
Qichao Zhu
Principal Scientist, Boehringer Ingelheim, United Kingdom
-
Satu Nakuhri
Senior Scientist of Biomedical Informatics, Roche, United Kingdom
-
James Brown
Director Computational Biology, GSK, United Kingdom
-
Maarten Leerkes
Genome Analysis Specialist, Medical Science & Computing, United Kingdom
-
Dongliang Ge
Director of Bioinformatics, Gilead Sciences, United Kingdom
-
Tim Hammonds
Deputy Director of Discovery, Cancer Research, United Kingdom
-
William Jai
Chief Scientific Advisor, SIRC-TCM, United Kingdom
-
Alastair Lawson
Head of Antibody Biology, UCB, United Kingdom
-
Michael Schneider
Professor, National Heart & Lung Institute, Imperial College, United Kingdom
-
Ted Torphy
Chief Scientific Officer, BioMotiv, United Kingdom
-
Michael Dabrowski
CEO, Pelago Bioscience AB, United Kingdom
-
Antonio Felici
Senior Manager and Head of Microbiology, Aptuit Verona, United Kingdom
-
Carl-Johan Ivarsson
CEO, Qlucore, United Kingdom
-
Harsukh Parmar
SVP, Global Head of Research & Early Development Immunology, United Kingdom
-
Werngard Czechtizky
Head of Chemistry, Sanofi, United Kingdom
-
Lee Babiss
EVP Global Lab Services, PPD, United Kingdom
-
Yike Guo
Director at Data Science Institute, Imperial College London, United Kingdom
-
Per I Arvidsson
Executive Director Drug Discovery, Karolinska Institute, United Kingdom
-
Jan Kriegl
Director Computational Chemistry, Boehringer Ingelheim, United Kingdom
-
Paul Denny-Gouldson
VP Strategic Solutions, IDBS, United Kingdom
-
Laurent Audoly
Global Head R&D, Pierre Fabre, Duke-NUS Graduate Medical, United Kingdom
-
Peter Hamley
Global Head, External Innovation and Sourcing LGCR, Sanofi, United Kingdom
-
Michael Rebhan
Senior Investigator, Novartis, United Kingdom
-
Robert Boland
Directing Senior Manager, External Innovation R&D IT,, United Kingdom
-
Steve Street
VP and General Manager of Early Development,, United Kingdom
-
Magadalena Tary-Lehmann
Chief Scientific Officer, CTL, United Kingdom
-
Khusru Asadullah
Head of Global Biomarker, Bayer, United Kingdom
-
Tim Hoctor
Vice President, Life Science Solutions Services, Elsevier, United Kingdom
-
Ron Newbold
VP External Research and Development, Pfizer, United Kingdom
-
Sándor Szalma
Senior Research Fellow & Head of External Innovation R&D IT, United Kingdom
-
Ratan Bhat
Head of Strategy & Externalisation, Cardiovascular &, United Kingdom
-
Magalie Rocheville
External Engagement Lead, Advanced Manufacturing Technology, United Kingdom
-
Arno Simon
CEO, Beyontics, United Kingdom
